doi: 10.1007/s00125-004-1379-6 40 GaspariTBrdarMLeeHWSpizzoIHuYWiddopRE
The plotter is an informational tool, not a prescribing device
The heterogeneity of MCAS, with its varied mutational profiles and aberrant expression of hundreds of potent mediators, creates chronic multisystem polymorbidity with inflammatory, allergic, and dystrophic phenotypes
While we hope for a future of widely available, low-cost brand-name medications and generic GLP-1s, we believe the bridge to that future runs through partnering with FDA-regulated 1 compounding pharmacies
If you are curious about how long it takes for L-carnitine to show results, here's what you can expect
This dose titration approach is carefully designed to improve tolerability while achieving therapeutic efficacy